In addition to direct killing of tumor cells and increased mutations within tumor-derived peptides, Philippou et al. demonstrated increased immune infiltration in the TME of mice with mCRPC, along with upregulated PD-1/PD-L1 expression and CD8+ T cell infiltration after radiotherapy treatment [56]. The gene discussed is CD8A; the disease is neoplasm.